Citadel Advisors - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 65 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q3 2023$196,552
+2040.2%
62,200
+347.7%
0.00%
Q2 2023$9,184
-19.4%
13,893
-2.8%
0.00%
Q1 2023$11,400
-98.0%
14,293
-94.4%
0.00%
Q4 2022$573,387
+124.0%
253,711
+90.8%
0.00%
Q3 2022$256,000
-48.5%
132,980
-0.5%
0.00%
Q2 2022$497,000
-66.2%
133,591
-40.7%
0.00%
Q1 2022$1,469,000
+247.3%
225,349
+520.2%
0.00%
Q4 2021$423,000
-55.4%
36,337
+1.6%
0.00%
Q4 2020$949,000
-82.7%
35,752
-85.4%
0.00%
-100.0%
Q3 2020$5,489,000245,0340.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,827,926$12,096,2468.11%
TCG Crossover Management, LLC 11,111,111$35,111,1115.17%
VR Adviser, LLC 14,444,444$45,644,4434.80%
Kynam Capital Management, LP 3,281,313$10,368,9491.70%
Ghost Tree Capital, LLC 1,325,000$4,187,0001.38%
Octagon Capital Advisors LP 2,777,778$8,777,7781.35%
RA Capital Management 18,472,503$58,373,1091.15%
RTW INVESTMENTS, LP 16,893,185$53,382,4651.13%
Diametric Capital, LP 760,014$2,401,6441.00%
Quantum Private Wealth, LLC 575,380$1,818,2010.87%
View complete list of TAYSHA GENE THERAPIES INC shareholders